Hikma Pharmaceuticals PLC current ratio

The Current Ratio as of November 2026 (TTM) for Hikma Pharmaceuticals PLC (HKMPY) is 1.98

According to Hikma Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current Current Ratio is 1.98. This represents a change of 28.04% compared to the average of 1.55 of the last 4 quarters.

Hikma Pharmaceuticals PLC (HKMPY) Historical Current Ratio (quarterly & annually)

How has HKMPY Current Ratio performed in the past?

The mean historical Current Ratio of Hikma Pharmaceuticals PLC over the last ten years is 1.70. The current 1.98 Current Ratio has changed 16.54% with respect to the historical average. Over the past ten years (40 quarters), HKMPY's Current Ratio was at its highest in in the December 2006 quarter at 2.81. The Current Ratio was at its lowest in in the December 2007 quarter at 0.93.

Hikma Pharmaceuticals PLC (HKMPY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hikma Pharmaceuticals PLC Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hikma Pharmaceuticals PLC (HKMPY) Average Current Ratio

How has HKMPY Current Ratio performed in the past?

The current Current Ratio of Hikma Pharmaceuticals PLC (HKMPY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hikma Pharmaceuticals PLC (HKMPY) Current Ratio vs. Peers

How is HKMPY’s Current Ratio compared to its peers?

Hikma Pharmaceuticals PLC’s Current Ratio is greater than Viatris Inc. (1.58), greater than Amneal Pharmaceuticals, Inc. (1.87), greater than Dr. Reddy's Laboratories Limited (1.93), less than ANI Pharmaceuticals, Inc. (2.91), less than Aspen Pharmacare Holdings Limited (2.54), greater than Bausch Health Companies Inc. (1.56), less than Amphastar Pharmaceuticals, Inc. (2.40), less than Elite Pharmaceuticals, Inc. (3.76), greater than HLS Therapeutics Inc. (1.05), greater than Merck KGaA (1.69),

Build a custom stock screener for Hikma Pharmaceuticals PLC (HKMPY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hikma Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hikma Pharmaceuticals PLC (HKMPY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hikma Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.